User login
Key clinical point: A higher preoperative multiparametric magnetic resonance imaging (mpMRI) Prostate Imaging Reporting and Data System (PI‐RADS) score is associated with upstaging on surgical pathology in patients with prostate cancer.
Major finding: PI-RADS score was greater than 3 in 87% of patients. Upstaging was reported in 47% of patients. PI-RADS was an independent risk predictor for upstaging (adjusted odds ratio, 2.034; P < .001).
Study details: A retrospective study of 294 patients with prostate cancer who underwent a prostate mpMRI and radical prostatectomy between 2016 and 2020.
Disclosures: No funding source was identified for this work. The authors declared no conflict of interests.
Source: Pockros B et al. Prostate. 2021 Dec 8. doi: 10.1002/pros.24280.
Key clinical point: A higher preoperative multiparametric magnetic resonance imaging (mpMRI) Prostate Imaging Reporting and Data System (PI‐RADS) score is associated with upstaging on surgical pathology in patients with prostate cancer.
Major finding: PI-RADS score was greater than 3 in 87% of patients. Upstaging was reported in 47% of patients. PI-RADS was an independent risk predictor for upstaging (adjusted odds ratio, 2.034; P < .001).
Study details: A retrospective study of 294 patients with prostate cancer who underwent a prostate mpMRI and radical prostatectomy between 2016 and 2020.
Disclosures: No funding source was identified for this work. The authors declared no conflict of interests.
Source: Pockros B et al. Prostate. 2021 Dec 8. doi: 10.1002/pros.24280.
Key clinical point: A higher preoperative multiparametric magnetic resonance imaging (mpMRI) Prostate Imaging Reporting and Data System (PI‐RADS) score is associated with upstaging on surgical pathology in patients with prostate cancer.
Major finding: PI-RADS score was greater than 3 in 87% of patients. Upstaging was reported in 47% of patients. PI-RADS was an independent risk predictor for upstaging (adjusted odds ratio, 2.034; P < .001).
Study details: A retrospective study of 294 patients with prostate cancer who underwent a prostate mpMRI and radical prostatectomy between 2016 and 2020.
Disclosures: No funding source was identified for this work. The authors declared no conflict of interests.
Source: Pockros B et al. Prostate. 2021 Dec 8. doi: 10.1002/pros.24280.